Evidence map›Paper›PMID 24553525›Full record

ArticleThe journal of trauma and acute care surgery2014

Complement mediates a primed inflammatory response after traumatic lung injury.

J Jason Hoth, Jonathan D Wells, Sarah E Jones, Barbara K Yoza, Charles E McCall

Open access · greenAbstract read
In one paragraph

Article in The journal of trauma and acute care surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The pulmonary pathology of COVID-19.Virchows Archiv : an international journal of pathology · 2021
    Review
  13. Review
  14. Article
  15. Innate immune responses to trauma.Nature immunology · 2018
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J Jason HothFrom the Department of General Surgery (J.J.H., J.D.W., B.K.Y.), and Section on Molecular Medicine (C.E.M.), Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Jonathan D Wells
Sarah E Jones
Barbara K Yoza
Charles E McCall
Wake Forest University · US

Funding

NF-kB and Chromatin Changes in Human SepsisR01AI065791 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2006 to 2015
$4.3M
Epigenetics of Severe Systemic InflammationR01AI079144 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2010 to 2014
$2.0M
Mitochondrial Biogenesis is Regulated by RelB During InflammationR01GM102497 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2014 to 2017
$1.2M
The Molecular and Cellular Response to Pulmonary ContusionK08GM083154 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOTH, JAMES JASON · 2008 to 2012
$698k
Metabolic and Immune Properties of SepsisR56AI065791 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2017 to 2017
$506k
Epigenetics of Severe Systemic InflammationR56AI079144 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, CHARLES EMORY · 2009 to 2009
$370k
NIAID NIH HHS AI06579NIAID NIH HHS AI079144NIAID NIH HHS R01 AI065791NIAID NIH HHS R01 AI079144NIAID NIH HHS R56 AI065791NIAID NIH HHS R56 AI079144NIGMS NIH HHS K08 GM083154NIGMS NIH HHS K08GM083154NIGMS NIH HHS R01 GM102497
6 · The paper itself

Abstract

backgroundPulmonary contusion (PC) is a common, potentially lethal injury that results in the priming for exaggerated responses to subsequent immune challenge such as an infection (second hit). We hypothesize a PC-induced complement (C) activation participates in the priming effect for a second hit.

methodsMale, 8 weeks to 9 weeks, C57BL/6 mice (wild-type, C5) underwent blunt chest trauma resulting in PC. At 3 hours/24 hours after injury, the inflammatory response was measured in tissue, serum, and bronchoalveolar lavage (BAL). The thrombin inhibitor, hirudin, was used to determine if injury-induced thrombin participated in the activation of C. Injury-primed responses were tested by challenging injured mice with bacterial endotoxin (lipopolysaccharide, LPS) as a second hit. Inflammatory responses were assessed at 4 hours after LPS challenge. Data were analyzed using one-way analysis of variance with Bonferroni multiple comparison posttest (significance, p ≤ 0.05). Protocols were approved by the Institutional Animal Care and Use Committee.

resultsWe found significantly increased levels of C5a in the BAL of injured animals as early as 24 hours, persisting for up to 72 hours after injury. Hirudin-treated injured mice had significantly decreased levels of thrombin in the BAL that correlated with reduced C5a levels. Injured mice challenged with intratracheal (IT) LPS had increased C5a and inflammatory response. Conversely, inhibition of C5a or its receptor, C5aR, before LPS challenge correlated with decreased inflammatory responses; C5a-deficient mice showed a similar loss of primed response to LPS challenge.

conclusionComplement C5a levels in the BAL are increased over several days after PC. Premorbid inhibition of thrombin markedly decreases C5a levels after PC, suggesting that thrombin-induced C activation is the major pathway of activation after PC. Similarly, inhibition of C5a after PC will decrease injury-primed responses to LPS stimulation. Our findings suggest cross-talk between the coagulation and complement systems that induce immune priming after PC.

Indexed as

AnimalsBronchoalveolar Lavage FluidComplement ActivationComplement C5aContusionsHirudinsHumansInflammationLipopolysaccharidesLung InjuryMaleMiceMice, Inbred C57BLReceptor, Anaphylatoxin C5aThrombinWounds, NonpenetratingComplement C5aHirudinsLipopolysaccharidesReceptor, Anaphylatoxin C5aThrombin

Identifiers

PMID24553525
PMCPMC4426490
OpenAlexW2032515719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.